indican has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, Y; Ishida, H; Ito, K; Kurabayashi, M; Kurosawa, K; Negishi, K; Obokata, M; Ogawa, T | 1 |
| Kompa, AR; Krum, H; Lekawanvijit, S; Liu, S; Wang, BH | 1 |
2 other study(ies) available for indican and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Echocardiography-based pressure-volume loop assessment in the evaluation for the effects of indoxyl sulfate on cardiovascular function.
Topics: Aged; Biomarkers; Echocardiography; Female; Follow-Up Studies; Humans; Hypertrophy, Left Ventricular; Indican; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction; Prognosis; Renal Dialysis; Stroke Volume; Systole; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2019 |
Antagonists of organic anion transporters 1 and 3 ameliorate adverse cardiac remodelling induced by uremic toxin indoxyl sulfate.
Topics: Animals; Cells, Cultured; Cilastatin; Fibroblasts; Indican; Myocytes, Cardiac; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Probenecid; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Uremia; Uricosuric Agents; Ventricular Remodeling | 2012 |